Grafta Nanotech Corp. (TSXV:GFTA)

Canada · Delayed Price · Currency is CAD

0.2250

-0.0750 (-25.00%)

At close: Sep 4, 2026

Grafta Nanotech Financials Overview

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Revenue	0.03	0.1	-
Revenue Growth	-	-	-
Gross Profit	0.01	0.06	-
Operating Income	-1.38	-1.19	-1.27
Net Income	2.41	2.49	-1.99
Earnings Per Share	0.04	0.05	-0.04
EPS Growth	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Investments	0.11	0.51	0.03
Total Debt	1.72	1.76	5.67
Net Cash (Debt)	-1.61	-1.24	-5.64
Net Cash Growth	-	-	-
Net Cash Per Share	-0.03	-0.02	-0.11

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Cash Flow	-0.78	-0.61	-0.41
Capital Expenditures	-	-	-0
Free Cash Flow	-0.78	-0.61	-0.41
Free Cash Flow Growth	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Gross Margin	32.70%	65.22%	-
Operating Margin	-4019.03%	-1248.17%	-
Pretax Margin	7000.57%	2604.07%	-
Profit Margin	7000.57%	2604.07%	-
FCF Margin	-2281.53%	-637.79%	-

Valuation

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Sep '26 Sep 5, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
PE Ratio	5.79	0.07	-
PS Ratio	502.09	1.89	-